Drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis

Abstract

Comparative analysis of drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis has been presented: it included dienogest monotherapy and combined interleukin-2 (il-2) and dienogest therapy. It has been proved that dienogest in combination with Interleukin-2 (ronkoleukin) followed by supportive therapy with dienogest-containing oral contraceptives (DCOK) is more effective for arresting pain syndrome, eliminating psycho-emotional disorders and preventing relapses.

Keywords

• синдром хронической тазовой боли
• эндометриоз
• диеногест
• ронколейкин
• диеногест-содержащие оральные контрацептивы
• chronic pelvic pain syndrome
• endometriosis
• roncoleukin
• dienogest
• dienogest-containing oral contraceptives